2,134
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Prophylactic treatment with Bacteroides uniformis and Bifidobacterium bifidum counteracts hepatic NK cell immune tolerance in nonalcoholic steatohepatitis induced by high fat diet

, , , , , , , & show all
Article: 2302065 | Received 07 Jul 2023, Accepted 02 Jan 2024, Published online: 09 Jan 2024

References

  • Stefan N, Schick F, Birkenfeld AL, Haring HU, White MF. The role of hepatokines in NAFLD. Cell Metab. 2023;35(2):236–20. doi:10.1016/j.cmet.2023.01.006.
  • Shashni B, Tajika Y, Ikeda Y, Nishikawa Y, Nagasaki Y. Self-assembling polymer-based short chain fatty acid prodrugs ameliorate non-alcoholic steatohepatitis and liver fibrosis. Biomaterials. 2023;295:122047. doi:10.1016/j.biomaterials.2023.122047.
  • Pinter M, Pinato DJ, Ramadori P, Heikenwalder M. NASH and hepatocellular carcinoma: immunology and immunotherapy. Clin Cancer Res. 2023;29(3):513–520. doi:10.1158/1078-0432.CCR-21-1258.
  • Klieser E, Mayr C, Kiesslich T, Wissniowski T, Fazio PD, Neureiter D, Ocker M. The crosstalk of miRNA and oxidative stress in the liver: from physiology to pathology and clinical implications. Int J Mol Sci. 2019;20(21):5266. doi:10.3390/ijms20215266.
  • Martinez-Chantar ML, Delgado TC, Beraza N. Revisiting the role of natural killer cells in non-alcoholic fatty liver disease. Front Immunol. 2021;12:640869. doi:10.3389/fimmu.2021.640869.
  • Tosello-Trampont AC, Krueger P, Narayanan S, Landes SG, Leitinger N, Hahn YS. NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice. Hepatology. 2016;63(3):799–812. doi:10.1002/hep.28389.
  • Michelet X, Dyck L, Hogan A, Loftus RM, Duquette D, Wei K, Beyaz S, Tavakkoli A, Foley C, Donnelly R. et al. Metabolic reprogramming of natural killer cells in obesity limits antitumor responses. Nat Immunol. 2018;19(12):1330–40. doi:10.1038/s41590-018-0251-7.
  • Wang F, Zhang X, Liu W, Zhou Y, Wei W, Liu D, Wong CC, Sung JJY, Yu J. Activated natural killer cell promotes nonalcoholic steatohepatitis through mediating JAK/STAT pathway. Cell Mol Gastroenterol Hepatol. 2022;13(1):257–274. doi:10.1016/j.jcmgh.2021.08.019.
  • Tumino N, Nava Lauson CB, Tiberti S, Besi F, Martini S, Fiore PF, Scodamaglia F, Mingari MC, Moretta L, Manzo T. et al. The tumor microenvironment drives NK cell metabolic dysfunction leading to impaired antitumor activity. Int J Cancer. 2023;152(8):1698–706. doi:10.1002/ijc.34389.
  • Sivori S, Pende D, Quatrini L, Pietra G, Della Chiesa M, Vacca P, Tumino N, Moretta F, Mingari MC, Locatelli F. et al. NK cells and ILCs in tumor immunotherapy. Mol Aspects Med. 2021;80:80. doi:10.1016/j.mam.2020.100870.
  • Gao Y, Souza-Fonseca-Guimaraes F, Bald T, Ng SS, Young A, Ngiow SF, Rautela J, Straube J, Waddell N, Blake SJ. et al. Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells. Nat Immunol. 2017;18(9):1004–15. doi:10.1038/ni.3800.
  • Yin H, Miao Z, Wang L, Su B, Liu C, Jin Y, Wu B, Han H, Yuan X. Fusobacterium nucleatum promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota. Aging (Albany NY). 2022;14:1941–58. doi:10.18632/aging.203914.
  • Tian P, Yang W, Guo X, Wang T, Tan S, Sun R, Xiao R, Wang Y, Jiao D, Xu Y. et al. Early life gut microbiota sustains liver-resident natural killer cells maturation via the butyrate-IL-18 axis. Nat Commun. 2023;14(1):1710. doi:10.1038/s41467-023-37419-7.
  • Jung YJ, Kim HS, Jaygal G, Cho HR, Lee KB, Song IB, Kim JH, Kwak MS, Han KH, Bae MJ. et al. Postbiotics enhance NK cell activation in stress-induced mice through gut microbiome regulation. J Microbiol Biotechnol. 2022;32(5):612–20. doi:10.4014/jmb.2111.11027.
  • Gui Q, Wang A, Zhao X, Huang S, Tan Z, Xiao C, Yang Y. Effects of probiotic supplementation on natural killer cell function in healthy elderly individuals: a meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2020;74(12):1630–7. doi:10.1038/s41430-020-0670-z.
  • Gutiérrez-Cuevas J, Lucano-Landeros S, López-Cifuentes D, Santos A, Armendariz-Borunda J. Epidemiologic, genetic, pathogenic, metabolic, epigenetic aspects involved in NASH-HCC: Current therapeutic strategies. Cancers. 2022;15(1). doi:10.3390/cancers15010023.
  • Castera L, Laouenan C, Vallet-Pichard A, Vidal-Trecan T, Manchon P, Paradis V, Roulot D, Gault N, Boitard C, Terris B. et al. High prevalence of NASH and advanced fibrosis in type 2 diabetes: a prospective study of 330 outpatients undergoing liver biopsies for elevated ALT, using a low threshold. Diab Care. 2023;46(7):1354–1362. doi:10.2337/dc22-2048.
  • Callegari IOM, Rocha GZ, Oliveira AG. Physical exercise, health, and disease treatment: the role of macrophages. Front Physiol. 2023;14:1061353. doi:10.3389/fphys.2023.1061353.
  • Zhou Y, Cheng L, Liu L, Li X. NK cells are never alone: crosstalk and communication in tumour microenvironments. Mol Cancer. 2023;22(1):34. doi:10.1186/s12943-023-01737-7.
  • Shen H, Cai X, Liu J, Yan G, Ye Y, Dong R, Wu J, Li L, Shen Q, Ma Y. et al. Case report: the clinical utility of metagenomic next-generation sequencing in mucormycosis diagnosis caused by fatal lichtheimia ramosa infection in pediatric neuroblastoma. Front Pediatr. 2023;11:1130775. doi:10.3389/fped.2023.1130775.
  • Jiang X, Melum E. The role of natural killer cells in nonalcoholic steatohepatitis: an ongoing debate. Cell Mol Gastroenterol Hepatol. 2022;13(1):348–349. doi:10.1016/j.jcmgh.2021.10.006.
  • Contreras D, Gonzalez-Rocha A, Clark P, Barquera S, Denova-Gutierrez E. Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: systematic review and meta-analysis. Ann Hepatol. 2023;28(1):100873. doi:10.1016/j.aohep.2022.100873.
  • Tada T, Saibara T, Ono M, Takahashi H, Eguchi Y, Hyogo H, Kawanaka M, Kumada T, Toyoda H, Yasuda S. et al. Predictive value of cytokeratin-18 fragment levels for diagnosing steatohepatitis in patients with nonalcoholic fatty liver disease. Eur J Gastroen Hepat. 2021;33(11):1451–1458. doi:10.1097/MEG.0000000000002176.
  • Ogawa K, Kobayashi T, Furukawa JI, Hanamatsu H, Nakamura A, Suzuki K, Kawagishi N, Ohara M, Umemura M, Nakai M. et al. Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis: a novel glycobiomarker for non-alcoholic steatohepatitis. Sci Rep. 2020;10(1):321. doi:10.1038/s41598-019-56947-1.
  • Turkseven S, Turato C, Villano G, Ruvoletto M, Guido M, Bolognesi M, Pontisso P, Di Pascoli M. Low-dose acetylsalicylic acid and mitochondria-targeted antioxidant mitoquinone attenuate non-alcoholic steatohepatitis in mice. Antioxid (Basel). 2023;12(4):971. doi:10.3390/antiox12040971.
  • Aziz N, Bonavida B. Activation of natural killer cells by probiotics. For Immunopathol Dis Therap. 2016;7(1–2):41–55. doi:10.1615/ForumImmunDisTher.2016017095.
  • Yang X, Guo Y, Chen C, Shao B, Zhao L, Zhou Q, Liu J, Wang G, Yuan W, Sun Z. Interaction between intestinal microbiota and tumour immunity in the tumour microenvironment. Immunology. 2021;164(3):476–93. doi:10.1111/imm.13397.
  • Yu Q, Newsome RC, Beveridge M, Hernandez MC, Gharaibeh RZ, Jobin C, Thomas RM. Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells. Gut Microbes. 2022;14(1):2112881. doi:10.1080/19490976.2022.2112881.
  • Thomas LM. Current perspectives on natural killer cell education and tolerance: emerging roles for inhibitory receptors. Immunotargets Ther. 2015;4:45–53. doi:10.2147/ITT.S61498.
  • Liu XH, Zhou JT, Yan CX, Cheng C, Fan JN, Xu J, Zheng Q, Bai Q, Li Z, Li S. et al. Single-cell RNA sequencing reveals a novel inhibitory effect of ApoA4 on NAFL mediated by liver-specific subsets of myeloid cells. Front Immunol. 2022;13:1038401. doi:10.3389/fimmu.2022.1038401.
  • Zhu J, Lin Q, Zheng H, Rao Y, Ji T. The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma. Front Oncol. 2022;12:897042. doi:10.3389/fonc.2022.897042.
  • Tabellini G, Baronio M, Patrizi O, Benevenuto A, Gazzurelli L, Plebani A, Parolini S, Lougaris V. The RAC2-PI3K axis regulates human NK cell maturation and function. Cl Immunol. 2019;208:208. doi:10.1016/j.clim.2019.108257.
  • Moncayo G, Lin D, Mccarthy MT, Watson AA, O’callaghan CA. MICA expression is regulated by cell adhesion and contact in a FAK/Src-dependent manner. Front Immunol. 2016;7:687. doi:10.3389/fimmu.2016.00687.
  • Su Y, Huang H, Luo T, Zheng Y, Fan J, Ren H, Tang M, Niu Z, Wang C, Wang Y. et al. Cell-in-cell structure mediates in-cell killing suppressed by CD44. Cell Discov. 2022;8(1):35. doi:10.1038/s41421-022-00387-1.
  • Kang HS, Liao G, Degraff LM, Gerrish K, Bortner CD, Garantziotis S, Jetten AM, Brennan L. CD44 plays a critical role in regulating diet-induced adipose inflammation, hepatic steatosis, and insulin resistance. PLoS One. 2013;8(3):e58417. doi:10.1371/journal.pone.0058417.
  • Kodama K, Toda K, Morinaga S, Yamada S, Butte AJ. Anti-CD44 antibody treatment lowers hyperglycemia and improves insulin resistance, adipose inflammation, and hepatic steatosis in diet-induced obese mice. DIABETES. 2015;64(3):867–75. doi:10.2337/db14-0149.
  • Zhang Z, Zheng M, Ding Q, Liu M. CD93 correlates with immune infiltration and impacts patient immunotherapy efficacy: a pan-cancer analysis. Front Cell Dev Biol. 2022;10:817965. doi:10.3389/fcell.2022.817965.
  • Sun Y, Chen W, Torphy RJ, Yao S, Zhu G, Lin R, Lugano R, Miller EN, Fujiwara Y, Bian L. et al. Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy. Sci Transl Med. 2021;13(604). doi:10.1126/scitranslmed.abc8922.
  • Zhao CZ, Jiang W, Zhu YY, Wang CZ, Zhong WH, Wu G, Chen J, Zhu MN, Wu QL, Du XL. et al. Highland barley Monascus purpureus went extract ameliorates high-fat, high-fructose, high-cholesterol diet induced nonalcoholic fatty liver disease by regulating lipid metabolism in golden hamsters. J Ethnopharmacol. 2022;286:114922. doi:10.1016/j.jep.2021.114922.
  • Xie L, Chen T, Qi X, Li H, Xie J, Wang L, Xie J, Huang Z. Exopolysaccharides from Genistein-Stimulated Monascus purpureus Ameliorate Cyclophosphamide-Induced Intestinal Injury via PI3K/AKT-MAPKs/NF-kappaB Pathways and Regulation of Gut Microbiota. J Agric Food Chem. 2023;71(35):12986–13002. doi:10.1021/acs.jafc.3c03186.
  • He GQ, Xiao L, Pan Z, Wu JR, Liang DN, Guo X, Jiang MY, Gao J. Case report: A rare case of pulmonary mucormycosis caused by Lichtheimia ramosa in pediatric acute lymphoblastic leukemia and review of Lichtheimia infections in leukemia. Front Oncol. 2022;12:949910. doi:10.3389/fonc.2022.949910.
  • Dai X, Zhou X, Shao R, Zhao R, Yanamandra AK, Xing Z, Ding M, Wang J, Liu T, Zheng Q. et al. Bioactive constituents of verbena officinalis alleviate inflammation and enhance killing efficiency of natural killer cells. Int J Mol Sci. 2023;24(8):7144. doi:10.3390/ijms24087144.
  • Frasca D, Blomberg BB. Inflammaging decreases adaptive and innate immune responses in mice and humans. Biogerontology. 2016;17(1):7–19. doi:10.1007/s10522-015-9578-8.
  • Hur MH, Song W, Cheon D-H, Chang Y, Cho YY, Lee YB, Yu SJ, Kim YJ, Yoon J-H, Choi HJ. et al. Chemogenetic stimulation of the parasympathetic nervous system lowers hepatic lipid accumulation and inflammation in a nonalcoholic steatohepatitis mouse model. Life Sci. 2023;321:121533. doi:10.1016/j.lfs.2023.121533.
  • Nunez SY, Ziblat A, Secchiari F, Torres NI, Sierra JM, Raffo Iraolagoitia XL, Araya RE, Domaica CI, Fuertes MB, Zwirner NW. Human M2 macrophages limit NK cell effector functions through secretion of TGF-beta and engagement of CD85j. J Immunol. 2018;200(3):1008–1015. doi:10.4049/jimmunol.1700737.
  • Park MD, Reyes-Torres I, Leberichel J, Hamon P, Lamarche NM, Hegde S, Belabed M, Troncoso L, Grout JA, Magen A. et al. TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer. Nat Immunol. 2023;24(5):792–801. doi:10.1038/s41590-023-01475-4.